Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03881930
Other study ID # K170911J
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date December 25, 2021

Study information

Verified date September 2021
Source Assistance Publique - Hôpitaux de Paris
Contact Bénédicte PANIGOT GUERIN, PT
Phone 01.40.05.41.73
Email benedicte.panigot@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research focuses on the effects of rehabilitation on balance, in patients with acquired chronic demyelinating neuropathy. Rehabilitation will be performed with or without vision. It is planned to include 40 subjects consulting for walking instability related to sensitivity disorders. This multicenter study will take place in Paris's area. Each participant will benefit from 20 rehabilitation sessions with a Physical Therapist and 3 assessments. Thanks to randomization, patient will be allocated in one of the 2 following groups: - Control group, Patients will benefit from balance rehabilitation with open eyes. - Experimental group, they will perform the same exercises while keeping their eyes closed or their vision will be obstructed by a mask or disturbed by moving luminous dots projected on the environment in darkness.


Description:

Patients with chronic acquired demyelinating neuropathy may be referred for instability or falls when walking. Some of them have complaints of dysesthesia, paresthesia. The majority of these patients, due to the involvement of large sensory fibres, have deep and superficial sensitivity disorders (hypoesthesia or anaesthesia), which explain proprioceptive ataxia and balance disorders. In a given situation, an individual maintains his or her balance thanks to sensory information, among which he or she may have to choose the most appropriate one for the context. A good balance control depends on the ability to select the best information, but many subjects do not have, or have lost, this ability, giving too systematically priority to the same sensory input. This is what is called sensory preferences or sensory profiles that differ from one subject to another. The most common behaviour is visual dependence. This tendency to visual dependence has been described in different pathological situations, especially after a stroke. Research has shown that specific rehabilitation in visual deprivation can reduce visual dependence and improve balance and walking autonomy in stroke patients. The investigators have shown in previous work that patients with acquired chronic demyelinating neuropathy have ataxic symptomatology with a visual dependence behavior, while a good sensitivity to vibration stimulation of proprioceptive pathways persists. The proprioceptive potential still present seems to be under-used. Rehabilitation of patients with peripheral neuropathy involves many techniques, such as muscle strengthening, vibration, virtual reality, Tai chi, electrical stimulation, etc. However, some techniques, such as the use of virtual reality or visual biofeedback, tend to increase the use of the visual input, which could be detrimental to other inputs. The specific approach to balance disorders in these patients through manipulation of the visual input has, to our knowledge, not been studied. This is the objective of the study. The main hypothesis of this research is that rehabilitation with modified visual input can, by reducing visual dependence, strengthen the proprioceptive input that still appears to be available in these patients with acquired chronic demyelinating neuropathy, despite deficits already present, and thus improve balance and walking ability.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 25, 2021
Est. primary completion date December 25, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with chronic demyelinating acquired neuropathy - Age = 18 years. - Patients able to walk 20 meters without human assistance at least indoors with or without technical assistance. - Patients with complaints such as discomfort, walking instability related to sensitivity disorders. - Patients being clinically stable for at least 2 months, regardless of ongoing treatments. - Patients who have provided consent. Exclusion Criteria: - Patients unable to walk 20 metres without technical and human assistance indoors. - Patients with an ongoing hospitalization. - Patients already included and participating in another intervention study. - Patients with ongoing balance rehabilitation and continued during the REQ-PRO program in another rehabilitation centre or practice. - Patients with ongoing acute treatment (related to polyneuropathy) started less than 2 months ago or stopped less than 2 months ago. - Patients with scheduled surgery during the period of the patient's participation in the protocol, preventing the successful completion of the rehabilitation program and participation in assessments. - Patients with recent surgery, in particular lower limb prosthesis (less than 1 year old) or equipment contraindicated for planned exercises such as standing kneeling positions. - Patients with skin wounds on the foot that contraindicate rehabilitation. - Patients with balance disorders of vestibular origin or central neurological pathology. - Patients with a visual disability. - Patients with a hearing impairment that prevents the patient from hearing and understanding instructions during the rehabilitation program or assessments. - Patients with an inability to speak or understand the French language. - Patients with cognitive or language impairments that prevent understanding of the protocol. - Patients with a residence outside of the Paris Region (Ile de France). - Patients with a known pregnancy. - Patients not affiliated to a social security system (beneficiary or having a right), deprived of their right, under guardianship, curatorship, prisoner.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Balance rehabilitation with modified visual input
Patients will perform the exercises alternatively: while keeping their eyes closed or their vision will be obstructed by a opaque mask or disturbed by moving luminous dots projected on the environment in a dark room without any visual reference cues.
Balance rehabilitation with no modified visual input
Patients will perform the exercises while keeping their eyes openned

Locations

Country Name City State
France Service de Médecine Physique et de Réadaptation (MPR) Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

References & Publications (6)

Barrois RP, Ricard D, Oudre L, Tlili L, Provost C, Vienne A, Vidal PP, Buffat S, Yelnik AP. Observational Study of 180° Turning Strategies Using Inertial Measurement Units and Fall Risk in Poststroke Hemiparetic Patients. Front Neurol. 2017 May 15;8:194. doi: 10.3389/fneur.2017.00194. eCollection 2017. — View Citation

Bonan IV, Yelnik AP, Colle FM, Michaud C, Normand E, Panigot B, Roth P, Guichard JP, Vicaut E. Reliance on visual information after stroke. Part II: Effectiveness of a balance rehabilitation program with visual cue deprivation after stroke: a randomized controlled trial. Arch Phys Med Rehabil. 2004 Feb;85(2):274-8. — View Citation

Filiatrault J, Gauvin L, Fournier M, Parisien M, Robitaille Y, Laforest S, Corriveau H, Richard L. Evidence of the psychometric qualities of a simplified version of the Activities-specific Balance Confidence scale for community-dwelling seniors. Arch Phys Med Rehabil. 2007 May;88(5):664-72. — View Citation

Missaoui B, Thoumie P. Balance training in ataxic neuropathies. Effects on balance and gait parameters. Gait Posture. 2013 Jul;38(3):471-6. doi: 10.1016/j.gaitpost.2013.01.017. Epub 2013 Mar 5. — View Citation

Provost CP, Tasseel-Ponche S, Lozeron P, Piccinini G, Quintaine V, Arnulf B, Kubis N, Yelnik AP. Standing postural reaction to visual and proprioceptive stimulation in chronic acquired demyelinating polyneuropathy. J Rehabil Med. 2018 Feb 28;50(3):278-284. doi: 10.2340/16501977-2314. — View Citation

Yelnik AP, Le Breton F, Colle FM, Bonan IV, Hugeron C, Egal V, Lebomin E, Regnaux JP, Pérennou D, Vicaut E. Rehabilitation of balance after stroke with multisensorial training: a single-blind randomized controlled study. Neurorehabil Neural Repair. 2008 Sep-Oct;22(5):468-76. doi: 10.1177/1545968308315996. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary U-turn time of realization, in seconds, realized at a comfortable speed measured with accelerometers just after the end of the rehabilitation program Evaluate balance during walking with a U-turn realized with eyes open at a comfortable speed by the time of realization, in seconds, of the U-turn, measured with accelerometers between 2 to 8 days after 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session
Secondary U-turn time of realization, in seconds, realized at comfortable speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn with eyes open realized at comfortable speed, by the time of realization, in seconds, of the U-turn measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary U-turn time of realization, in seconds, realized at fast speed, measured with accelerometers just after the end of the rehabilitation program. Evaluate balance during walking with a U-turn with eyes open realized at fast speed, by the time of realization, in seconds, of the U-turn measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary U-turn time of realization, in seconds, realized at fast speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn with eyes open realized at fast speed, by the time of realization, in seconds, of the U-turn measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Number of external steps of the U-turn realized at a comfortable speed, measured with accelerometers just after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at comfortable speed by the number of external steps of the U-turn measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Number of external steps of the U-turn realized at a comfortable speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at a comfortable speed by the number of external steps of the U-turn measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Number of external steps of the U-turn realized at fast speed, measured with accelerometers just after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at fast speed by the number of external steps of the U-turn measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Number of external steps of the U-turn realized at fast speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at fast speed by the number of external steps of the U-turn measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary The double stance phase time, walking 20 meters, realized at a comfortable speed, measured with accelerometers just after the end of the rehabilitation program Evaluate balance during walking with a U-turn realized with eyes open at comfortable speed by the double stance phase in %, to walk 20 meters, measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary The double stance phase, walking 20 meters, realized at a comfortable speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at a comfortable speed by the double stance phase in %, to walk 20 meters, measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary The double stance phase, walking 20 meters during walking with a U-turn, realized at fast speed, measured with accelerometers just after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at fast speed by the double stance phase in %, to walk 20 meters, measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary The double stance phase, walking 20 meters, realized at fast speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at fast speed by the double stance phase in %, to walk 20 meters, measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Global amount of movement during walking with a U-turn realized at a comfortable speed, measured with accelerometers just after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at comfortable speed by global amount of movement (related to oscillations and abruptness of the gesture) measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Global amount of movement during walking with a U-turn, realized at a comfortable speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at a comfortable speed by global amount of movement (related to oscillations and abruptness of the gesture), measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Global amount of movement during walking with a U-turn realized at fast speed, measured with accelerometers just after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at fast speed by the global amount of movement (related to oscillations and abruptness of the gesture), measured with accelerometers between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Global amount of movement during walking with a U-turn realized at fast speed, measured with accelerometers 2 months after the end of the rehabilitation program. Evaluate balance during walking with a U-turn realized with eyes open at fast speed by global amount of movement (related to oscillations and abruptness of the gesture), measured with accelerometers between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Time in seconds, to walk 10 meters, realized with open eyes at a comfortable speed just after the end of the rehabilitation program. Evaluate the balance by the Time in seconds, to walk 10 meters, realized with open eyes at a comfortable speed between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Time in seconds, to walk 10 meters, realized with open eyes at a comfortable speed 2 months after the end of the rehabilitation. Evaluate the balance by the Time in seconds, to walk 10 meters, realized with open eyes at a comfortable speed between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary The number of steps, to walk 10 meters with open eyes at a comfortable speed just after the end of the rehabilitation Evaluate the balance by the the number of steps, to walk 10 meters with open eyes at a comfortable speed between 2 to 8 days after the 20th and last rehabilitation session Between 2 to 8 days after the 20th and last rehabilitation session
Secondary The number of steps, to walk 10 meters with open eyes at a comfortable speed 2 months after the end of the rehabilitation Evaluate the balance by the the number of steps, to walk 10 meters with open eyes at a comfortable speed between 60 to 70 days after the 20th and last rehabilitation session Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary The Goggle Task performed just after the end of the rehabilitation program Evaluate the balance by the Goggle Task, the ratio: time in seconds, to walk 10 meters, in visual deprivation at comfortable speed / time in seconds, to walk 10 meters, eyes open at comfortable speed just after the end of the rehabilitation program. Between 2 to 8 days after the 20th and last rehabilitation session
Secondary The Goggle Task performed 2 months after the end of the rehabilitation Evaluate the balance by the Goggle Task, the ratio: time in seconds, to walk 10 meters, in visual deprivation at comfortable speed / time in seconds, to walk 10 meters, eyes open at comfortable speed between 60 to 70 days after the 20th and last rehabilitation session Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary The times, in seconds, of descent and ascent of a staircase floor, realized just after the end of the rehabilitation program Evaluate balance by the times, in seconds, of descent and ascent of a staircase floor, realized with open eyes between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary The times, in seconds, of descent and ascent of a staircase floor, realized 2 months after the end of the rehabilitation Evaluate balance by the times, in seconds, of descent and ascent of a staircase floor, realized with open eyes between 60 to 70 days after the 20th and last rehabilitation session Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Romberg quotient collected just after the end of the rehabilitation program. Evaluate balance by the Romberg quotient collected during a static stabilometry test between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session
Secondary Romberg quotient collected 2 months after the end of the rehabilitation Evaluate balance by the Romberg quotient collected during a static stabilometry test between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Sensory preference realized just after the end of the rehabilitation program Determine the sensory profile of the patient by the sensory preference score after visual and proprioceptive stimuli between 2 to 8 days after the 20th and last rehabilitation session Between 2 to 8 days after the 20th and last rehabilitation session
Secondary Sensory preference realized 2 months after from the end of the rehabilitation Determine the sensory profile of the patient by the sensory preference score after visual and proprioceptive stimuli between 60 to 70 days after the 20th and last rehabilitation session between 60 to 70 days after the 20th and last rehabilitation session
Secondary Monofilament test 10 g just after the end of the rehabilitation program. Evaluate the superficial sensitivity to tact on the sole of the foot by the monofilament test 10 g (Semmes-Weinstein 5.07) between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Monofilament test 10 g, 2 months after the end of the rehabilitation. Evaluate the superficial sensitivity to tact on the sole of the foot by the monofilament test 10 g (Semmes-Weinstein 5.07) between 60 to 70 days after the 20th and last rehabilitation session. Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Score of kinesthetic sensitivity in the lower limbs just after the end of the rehabilitation program Evaluate sensitivity by a score of kinesthetic sensitivity in the lower limbs between 2 to 8 days Between 2 to 8 days after the 20th and last rehabilitation session
Secondary Score of kinesthetic sensitivity in the lower limbs, 2 months after the end of the rehabilitation. Evaluate sensitivity by a score of kinesthetic sensitivity in the lower limbs between 60 to 70 days Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Merkies palatal score in the lower limbs just after the end of the rehabilitation program Evaluate sensitivity by the Merkies palatal score in the lower limbs between 2 to 8 days after the 20th and last rehabilitation session. Between 2 to 8 days after the 20th and last rehabilitation session
Secondary Merkies palatal score in the lower limbs 2 months after the end of the rehabilitation Evaluate sensitivity by the Merkies palatal score in the lower limbs between 60 to 70 days after the 20th and last rehabilitation session Between 60 to 70 days after the 20th and last rehabilitation session.
Secondary Simplified version of the "Activities-specific Balance Confidence scale just after the end of the rehabilitation program Evaluate the person's confidence in his or her balance, in the activities of daily living Simplified version of the "Activities-specific Balance Confidence scale between 2 to 8 days:the 20th and last rehabilitation session.
Questionnaire made of 15 statements to assess the person's degree of confidence in his or her balance associated with activities of daily life in both the home environment and in the community environment. The questionnaire is part of this research administered by the evaluator.
Add the scores obtained to the 15 items to obtain an overall score out of 45. The score is converted to a pourcentage.
Between 2 to 8 days after the 20th and last rehabilitation session.
Secondary Simplified version of the "Activities-specific Balance Confidence scale 2 months after the end of the rehabilitation. Evaluate the person's confidence in his or her balance, in the activities of daily living Simplified version of the "Activities-specific Balance Confidence scale between ¬60 to 70 days: the 20th and last rehabilitation session.
Questionnaire made of 15 statements to assess the person's degree of confidence in his or her balance associated with activities of daily life in both the home environment and in the community environment. The questionnaire is part of this research administered by the evaluator.
Add the scores obtained to the 15 items to obtain an overall score out of 45. The score is converted to a pourcentage.
Between 60 to 70 days after the 20th and last rehabilitation session.
See also
  Status Clinical Trial Phase
Completed NCT03195868 - Photobiomodulation Therapy and Nerve Density for Patients With Diabetic or Chemotherapy-associated Neuropathy N/A
Not yet recruiting NCT05565469 - Correlation Between Abdominal Wall Stimulation and Neurostimulator Tip Location N/A
Completed NCT02309164 - The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN). N/A
Completed NCT00775645 - S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy Phase 3
Completed NCT03624426 - Detection and Prevention of Nerve Injury in Shoulder Arthroplasty Surgery N/A
Withdrawn NCT03436680 - Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy N/A
Completed NCT05691738 - Effects of Modified Otago Exercises in Individuals With Diabetic Neuropathy N/A
Completed NCT05095870 - Evaluation of the Peripheral Nerve Ultrasound as a Diagnostic Tool in CANVAS Neuropathies
Completed NCT02615678 - Acupuncture for CIPN in Breast Cancer Patients N/A
Completed NCT02011282 - Electro-Neuro-Muscular Stimulation in ICU N/A
Recruiting NCT01774058 - The Arterial Measurement of the Blood Flow Volume After Iloprost Stimulation Phase 2
Completed NCT01135251 - Safety and Preliminary Evidence of Efficacy of Escalating Doses of Dimiracetam in AIDS Patients With Painful Neuropathy Phase 2
Recruiting NCT06324344 - Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy Induced Peripheral Neuropathy (CIPN) N/A
Recruiting NCT04403802 - Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy N/A
Recruiting NCT04579406 - Perioperative Adverse Cardiovascular Event in Type-2 Diabetic Patients
Completed NCT03909464 - Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
Completed NCT01523132 - Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms N/A
Completed NCT02689661 - Impact of the Metabolic Syndrome on the Incidence of Neuropathy in Obese Subjects
Terminated NCT00998738 - Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer Phase 3
Withdrawn NCT00528593 - Epoetin Alfa for HIV-Associated Neuropathy Trial Phase 2